TMV-COAT PROTEIN IN ENGINEERED RESISTANCE
工程抗性中的 TMV 涂层蛋白
基本信息
- 批准号:2063723
- 负责人:
- 金额:$ 29.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-02-01 至 1997-04-30
- 项目状态:已结题
- 来源:
- 关键词:RNA biosynthesis RNase protection assay capsid computer simulation electron microscopy gene expression genetically modified plants host organism interaction mutant physical model plant genetics protein engineering protein structure function protoplast /spheroplast site directed mutagenesis tobacco tobacco mosaic virus transposon /insertion element virion virus RNA virus cytopathogenic effect virus genetics virus infection mechanism virus replication
项目摘要
In 1986 this laboratory reported (Science 232:738-743) that transgenic
tobacco plants that express a gene encoding the capsid protein (CP) of
tobacco mosaic virus (TMV) are substantially protected against infection by
TMV. This type of resistance, "coat-protein mediated resistance (CP-MR)",
has been used to develop resistance against many different types of viruses
in a number of types of plants. Although the successes of CP-MR are well
known, and advanced stages of testing and evaluation of transgenic plant
lines are in progress, the cellular and molecular mechanisms of resistance
are not yet known.
The system best-suited for in-depth study is TMV and transgenic tobacco and
tomato plants. Published information of the crystal structure of TMV-CP
and x-ray fiber diffraction studies of TMV will be used to create mutant
proteins to investigate the role of protein structure, protein:protein, and
protein:RNA interactions on CP-MR. The effects of wild-type and mutant CPs
on virus uncoating, establishment of infection, and local and systemic
spread of virus in transgenic plants and synchronously infected protoplasts
will be determined.
To study early events in virus uncoating in CP-MR an epitope-tagging
approach will be taken to follow virus disassembly and protein exchange
reactions. To monitor localized spread of the infection in CP-MR, virus
replication will be followed in real time by imaging and recording the
expression of a luciferase gene that has been incorporated into the virus.
To explore the role that expression of the TMV-CP gene in specific cell
types has on resistance, transgenic plant lines will be developed that
express the CP gene under control of inducible, tightly regulated
promoters. Promoters controlled by wounding or added reagents and
promoters expressed specifically in epidermal and vascular xylem cells,
vascular phloem cells, and in chloroplast containing cells will be used
singly or in combination to examine the role of CP in various aspects of
virus infection and disease development.
Interfacing structural chemistry, protein modeling, molecular genetics,
cell biology, and virology as described here represents a novel approach to
studies of viral pathogenesis. It will also lead to better understanding
of CP-MR and further develop transgenic resistance for use in food
production to decrease the often severe virus infections that limit food
availability and exacerbate hunger in many parts of the world.
1986年,该实验室报告(Science 232:738-743)转基因
表达编码烟草衣壳蛋白(CP)基因的烟草
烟草花叶病毒(TMV)实质上是通过
烟草花叶病毒。这种抗性称为“外壳蛋白介导的抗性(CP-MR)”,
已经被用来对许多不同类型的病毒产生抵抗力
在许多类型的植物中。尽管CP-MR的成功之处在于
转基因植物检测和评估的已知和高级阶段
品系研究进展,抗性的细胞和分子机制
还不为人所知。
最适合深入研究的系统是烟草花叶病毒和转基因烟草以及
番茄植株。已发表的TMV-CP晶体结构信息
而烟草花叶病毒的x射线纤维衍射研究将被用于创造突变体
蛋白质研究蛋白质结构的作用,蛋白质:蛋白质,和
蛋白质:CP-MR上的RNA相互作用野生型和突变型CPS的作用
关于病毒的脱壳,感染的建立,以及局部和系统的
病毒在转基因植物和同步感染原生质体中的传播
将会被确定。
CP-MR An表位标记法研究病毒脱壳的早期事件
将采取方法来跟踪病毒的分解和蛋白质交换
反应。监测CP-MR病毒感染的局部传播
复制之后将实时成像和记录
已经整合到病毒中的荧光素酶基因的表达。
探讨TMV-CP基因在特定细胞中表达的作用
没有抗性的类型,将开发出转基因植物系
在可诱导的、严格调控的控制下表达CP基因
推动者。受伤害或添加试剂控制的启动子和
启动子在表皮和维管木质部细胞中特异表达,
维管束韧皮部细胞,以及在叶绿体中含有的细胞都会用到
单独或组合研究CP在不同方面的作用
病毒感染和疾病发展。
界面结构化学、蛋白质建模、分子遗传学、
这里描述的细胞生物学和病毒学代表了一种新的方法
病毒致病机制的研究。这也将带来更好的理解
CP-MR和进一步发展转基因抗性在食品中的应用
生产以减少通常严重的限制食物的病毒感染
在世界许多地区,粮食供应不足并加剧了饥饿。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roger Beachy其他文献
Roger Beachy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roger Beachy', 18)}}的其他基金
Intracellular targeting of RNAs in virus infection
病毒感染中 RNA 的细胞内靶向
- 批准号:
6636630 - 财政年份:2001
- 资助金额:
$ 29.94万 - 项目类别:
Intracellular targeting of RNAs in virus infection
病毒感染中 RNA 的细胞内靶向
- 批准号:
6730653 - 财政年份:2001
- 资助金额:
$ 29.94万 - 项目类别:
Intracellular targeting of RNAs in virus infection
病毒感染中 RNA 的细胞内靶向
- 批准号:
6520470 - 财政年份:2001
- 资助金额:
$ 29.94万 - 项目类别:
Intracellular targeting of RNAs in virus infection
病毒感染中 RNA 的细胞内靶向
- 批准号:
6320172 - 财政年份:2001
- 资助金额:
$ 29.94万 - 项目类别:
TMV-COAT PROTEIN IN ENGINEERED CROSS-PROTECTION
工程交叉保护中的 TMV 涂层蛋白
- 批准号:
3141284 - 财政年份:1989
- 资助金额:
$ 29.94万 - 项目类别:
TMV-COAT PROTEIN IN ENGINEERED CROSS-PROTECTION
工程交叉保护中的 TMV 涂层蛋白
- 批准号:
3141280 - 财政年份:1989
- 资助金额:
$ 29.94万 - 项目类别:
TMV-COAT PROTEIN IN ENGINEERED CROSS-PROTECTION
工程交叉保护中的 TMV 涂层蛋白
- 批准号:
3141283 - 财政年份:1989
- 资助金额:
$ 29.94万 - 项目类别:
相似海外基金
NOVEL RNASE PROTECTION ASSAY FOR CYTOKINE MRNAS
细胞因子 MRNAS 的新型 RNA 酶保护测定
- 批准号:
6317727 - 财政年份:2000
- 资助金额:
$ 29.94万 - 项目类别: